Jazz Pharmaceuticals JAZZ Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's shares (basic)?
- Jazz Pharmaceuticals (JAZZ) reported shares (basic) of 61.9M in Q1 2026.
- How has Jazz Pharmaceuticals's shares (basic) changed year-over-year?
- Jazz Pharmaceuticals's shares (basic) increased by 1.5% year-over-year, from 61M to 61.9M.
- What is the long-term trend for Jazz Pharmaceuticals's shares (basic)?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's shares (basic) has grown at a 0.7% compound annual growth rate (CAGR), from 236.9M to 243.9M.
- What does shares (basic) mean?
- The average number of common shares held by investors throughout the reporting period.
- How do you interpret shares (basic)?
- An increase often signals share issuance for capital raising or acquisitions, while a decrease typically reflects share buyback programs.
- How does shares (basic) compare across companies?
- Standardized metric; used to normalize earnings across different periods and companies.